Cargando…

Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect

In the setting of hematopoietic stem cell transplantation (HSCT), Rituximab (RTX) is used for the treatment and prevention of EBV-associated post-transplantation lymphoproliferative disease or autoimmune phenomena such as autoimmune hemolytic anemia (AIHA). Persistent hypogammaglobulinemia and immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ott de Bruin, Lisa M., Pico-Knijnenburg, Ingrid, van Ostaijen-ten Dam, Monique M., Weitering, Thomas J., Berghuis, Dagmar, Bredius, Robbert G. M., Lankester, Arjan C., van der Burg, Mirjam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649739/ https://www.ncbi.nlm.nih.gov/pubmed/37958995 http://dx.doi.org/10.3390/ijms242116012

Ejemplares similares

T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
por: Melsen, Janine E., et al.
Publicado: (2022)

Normal Numbers of Stem Cell Memory T Cells Despite Strongly Reduced Naive T Cells Support Intact Memory T Cell Compartment in Ataxia Telangiectasia
por: Weitering, Thomas J., et al.
Publicado: (2021)

Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT
por: Luterbacher, Fanny, et al.
Publicado: (2021)

Rituximab Use and Hypogammaglobulinemia
por: Alhassan, Eaman, et al.
Publicado: (2020)

B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children
por: van der Maas, Nicolaas G., et al.
Publicado: (2019)

Second Tier Testing to Reduce the Number of Non-actionable Secondary Findings and False-Positive Referrals in Newborn Screening for Severe Combined Immunodeficiency
por: Blom, Maartje, et al.
Publicado: (2021)

Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
por: Ohmoto, Akihiro, et al.
Publicado: (2022)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
por: Khojah, Amer M., et al.
Publicado: (2019)

Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab
por: Perriguey, Marine, et al.
Publicado: (2021)

Future Perspectives of Newborn Screening for Inborn Errors of Immunity
por: Blom, Maartje, et al.
Publicado: (2021)

The Same IκBα Mutation in Two Related Individuals Leads to Completely Different Clinical Syndromes
por: Janssen, Riny, et al.
Publicado: (2004)

Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool
por: van der Stoep, M. Y. Eileen C., et al.
Publicado: (2021)

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
por: Barmettler, Sara, et al.
Publicado: (2018)

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
por: Marcinnò, Andrea, et al.
Publicado: (2018)

Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
por: Damianaki, Anthie, et al.
Publicado: (2022)

Modeling Influencing Factors in B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation in Children
por: van der Maas, Nicolaas G., et al.
Publicado: (2021)

Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
por: Farhat, Lara, et al.
Publicado: (2018)

Hypogammaglobulinemia following COVID-19 infection in a patient on maintenance rituximab
por: O’Bryan, Collin, et al.
Publicado: (2021)

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
por: Tariq, Anam, et al.
Publicado: (2022)

PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?
por: Trujillo, Juan Enrique, et al.
Publicado: (2014)

Hypogammaglobulinemia Observed One Year after Rituximab Treatment for Idiopathic Thrombocytopenic Purpura
por: Shoukat, Bilal Ahmad, et al.
Publicado: (2018)

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021)

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
por: Zurowska, Aleksandra, et al.
Publicado: (2023)

Single-cell transcriptomics in bone marrow delineates CD56(dim)GranzymeK(+) subset as intermediate stage in NK cell differentiation
por: Melsen, Janine E., et al.
Publicado: (2022)

Human Bone Marrow-Resident Natural Killer Cells Have a Unique Transcriptional Profile and Resemble Resident Memory CD8(+) T Cells
por: Melsen, Janine E., et al.
Publicado: (2018)

Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
por: Boerman, Gerharda H., et al.
Publicado: (2015)

Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome
por: Counsilman, Clare E., et al.
Publicado: (2015)

Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
por: Besada, Emilio
Publicado: (2016)

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study
por: Wade, Stefanie D., et al.
Publicado: (2021)

Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?
por: Ren, Jingru, et al.
Publicado: (2023)

Optimizing diagnostic methods and stem cell transplantation outcomes in pediatric bone marrow failure: a 50-year single center experience
por: Vissers, Lotte, et al.
Publicado: (2023)

Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab
por: Besada, Emilio
Publicado: (2016)

Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition?
por: Viallard, Jean-François, et al.
Publicado: (2019)

Hypogammaglobulinemia with Facial Edema
por: Knight, Adina Kay, et al.
Publicado: (2006)

An unusual presentation of a patient with severe hypogammaglobulinemia
por: Hoffman, Thijs W., et al.
Publicado: (2018)

Economic Evaluation of Different Screening Strategies for Severe Combined Immunodeficiency Based on Real-Life Data
por: van den Akker-van Marle, M. Elske, et al.
Publicado: (2021)

Biallelic PAX5 mutations cause hypogammaglobulinemia, sensorimotor deficits, and autism spectrum disorder
por: Kaiser, Fabian M.P., et al.
Publicado: (2022)

Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values
por: Marzuillo, Pierluigi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b5a8j5lll623c3d0uqn37khe6q